Evidence map›Paper›PMID 39659429›Full record

ArticleAdvances in hematology2024

Relationships Between Markers of Iron Status and Hematological Parameters in Patients With Sickle Cell Disease.

Nermi L Parrow, Jason M Doherty, Anna Conrey, Swee Lay Thein, Robert E Fleming

Abstract read
In one paragraph

Article in Advances in hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nermi L ParrowDepartment of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0003-4504-5512
Jason M DohertyAdvanced HEAlth Data (AHEAD) Research Institute, Saint Louis University School of Medicine, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0002-9399-8214
Anna ConreySickle Cell Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Swee Lay TheinSickle Cell Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-9835-6501
Robert E FlemingDepartment of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0003-0154-4483

Funding

Studies of the Natural History of Sickle Cell DiseaseZIAHL006233 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI THEIN, SWEE LAY · 2017 to 2025
$10.9M
Regulatory Role of Transferrin in Erythropoiesis and Iron MetabolismR01DK095112 · NIDDK · SAINT LOUIS UNIVERSITY · PI Robert E Fleming, Yelena Ginzburg · 2012 to 2026
$5.4M
Intramural NIH HHS ZIA HL006233NIDDK NIH HHS R01 DK095112
6 · The paper itself

Abstract

Based on the relationship between the intracellular concentration of sickle hemoglobin S (HbS) and the delay that occurs prior to the onset of sickling following deoxygenation, targeting the intracellular HbS concentration is a recognized therapeutic approach for sickle cell disease (SCD). We and others have shown that restricting iron by dietary or pharmacologic means improves hematologic parameters, inflammation, and organ damage in mouse models of SCD. Clinical evidence corroborating these findings is confined to case reports and small case series studies, none of which account for treatment or

Indexed as

ironmean cellular hemoglobin concentrationsickle cell diseasetransferrin saturation

Identifiers

PMID39659429
PMCPMC11631288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.